Table 4.
Detailed overview on surgical procedures and in-house mortality/LT.
| n in-house death or LT/n operations | n in-house death or LT/n operations | |
|---|---|---|
| Low-risk surgery | TIPS cohort (n = 30) | Control cohort (n = 61) |
| Elective orthopaedic surgery | 0/6 (0% dead) | 2/4 (50% dead/LT) |
| Spondylodiscitis | 0/1 (0% dead) | – |
| Kyphoplasty | 0/2 (0% dead) | 0/2 (0% dead) |
| Nail osteosynthesis (femoral/humoral) | 0/2 (0% dead) | 1/1 (100% LT) |
| Hip endoprosthesis | 0/1 (0% dead) | 1/1 (100% dead) |
| Hernia repair | 0/9 (0% dead) | 2/22 (9% dead) |
| Laparoscopic interventions | 0/4 (0% dead) | 5/28 (18% dead) |
| Cholecystectomy | 0/2 (0% dead) | 0/10 (0% dead) |
| Abdominal haematoma evacuation | 0/1 (0% dead) | 1/3 (33% dead) |
| Sleeve gastrectomy | 0/1 (0% dead) | 1/9 (11% dead) |
| Sigmoidostomy | – | 0/1 (0% dead) |
| Explorations | – | 2/2 (100% dead) |
| Lung resection/pleurectomy | – | 1/3 (33% dead) |
| Other | 0/11 (0% dead) | 1/7 (14% dead) |
| Abscess cleavage and necrotic wound debridement | 0/2 (0% dead) | 1/4 (25% dead) |
| Oesophageal endoscopic mucosa dissection | 0/2 (0% dead) | – |
| Bladder tamponade clearance | 0/1 (0% dead) | – |
| Mandibular vestibuloplasty | 0/2 (0% dead) | – |
| Tracheotomy | 0/2 (0% dead) | – |
| Circumcision | 0/1 (0% dead) | – |
| Lymph node extirpation | 0/1 (0% dead) | 0/1 (0% dead) |
| Thyroidectomy |
– |
0/2 (0% dead) |
| High-risk surgery | TIPS cohort (n = 34) | Control cohort (n = 70) |
| Emergency orthopaedic surgery | 0/1 (0% dead) | 2/2 (100% dead) |
| Dislocated humerus fracture | 0/1 (0% dead) | – |
| Destructive spondylodiscitis | – | 2/2 (100% dead) |
| Thoracotomy | 0/5 (0% dead) | 3/6 (50% dead/LT) |
| Decortication and pleurectomy | 0/3 (0% dead) | 2/3 (66% dead/LT) |
| Lung resection | 0/2 (0% dead) | 1/3 (33% dead) |
| Open abdominal surgery | 12/27 (44% dead/LT) | 36/61 (59% dead) |
| Shunt surgery with splenectomy | 0/1 (0% dead) | 0/2 (0% dead) |
| Pancreatectomy (including Whipple procedure) | 1/4 (25% LT) | 1/3 (33% dead) |
| Bowel resection (ileo- and/or colectomy) | 4/11 (36% dead) | 24/36 (67% dead) |
| Kidney transplantation | 0/1 (0% dead) | – |
| Gastrectomy | 2/4 (50% dead) | 3/8 (38% dead) |
| Cholecystectomy | 1/2 (50% dead) | 1/2 (50% dead) |
| Oesophagectomy | 3/3 (100% dead) | 6/9 (67% dead) |
| Abdominal compartment as a result of bleeding | 1/1 (100% dead) | – |
| Intra-abdominal abscess cleavage | – | 1/1 (100% dead) |
| Other | 0/1 (0% dead) | 1/1 (100% dead) |
| Subcutaneous abscess with resection of thesternum | 0/1 (0% dead) | – |
| Emergency foot amputation (gangrene) | – | 1/1 (100% dead) |
The incidence of in-house mortality/LT is lower in the TIPS cohort after both low-risk and high-risk surgery. Numbers in bold indicate the incidence of in-house mortality/LT of the respective subcategory.
LT, liver transplantation; TIPS, transjugular intrahepatic portosystemic shunt.